Canopy Growth (TSX:WEED)(NYSE:CGC) is a favourite among cannabis investors. With a $10.3 billion market cap, the stock is priced above nearly every competitor. One of the biggest reasons for this valuation is Canopy’s partnership with Constellation Brands. With a $40 billion valuation, Constellation is an industry heavyweight, too. But instead of pot, Constellation is focused on alcohol. Last year, it…
Read More
While the battle among Canadian marijuana producers for Europe market dominance continues to shape up in 2020, clear winners are emerging judging from recent licensing developments, capacity analysis and related strategic moves from the respective challengers. Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Canopy Growth have enjoyed some first mover advantage after reporting some significant sales run rates in Germany over the past…
Read More
After booming for more than three years, the marijuana bubble started to burst in 2018 following legalization. The downhill move continued in 2019. Marijuana companies failed to meet expectations on revenue, as they had to face oversupply problems. It looks like the demand for cannabis was overestimated, and the hype has faded. With the sharp decline in stock prices, we…
Read More
Aphria (TSX:APHA)(NYSE:APHA) was one of the better-performing cannabis stocks of 2019. Although its stock declined in value for the year, it fell less than most of its peers thanks to two consecutive quarters of positive net income. Aphria’s positive earnings results in 2019 were a surprise to most investors. Cannabis stocks had broadly been expected to lose money, and few expected…
Read More
Demand for legal pot continues to climb to new heights. Investment bank Cowen Inc has raised its 2030 sales forecast from $75 billion to $80 billion, only to bump it again to $85 billion last November. Globally, several analysts are now expecting sales to peak above $200 billion. If adjacent markets are any indication, even these rosy estimates could prove…
Read More
On January 1, 2020, Illinois became the 11th state to legalize recreational marijuana. Throughout the course of the first day, sales topped $3.2 million dollars. Eager customer swarmed dispensaries to be among the first in the state to legally purchase cannabis products. Undoubtedly, this also brought increased revenue to surrounding businesses – including restaurants that worked with dispensaries. Given long…
Read More
Marijuana stocks had a tough run in the first year of legal recreational cannabis sales in Canada. The industry initially struggled with supply shortages and distribution problems when the market launched in Q4 last year. This led to an investor exodus with many of the leading pot stocks tumbling 40-50% in a matter of weeks. Canopy Growth (TSX:WEED)(NYSE:CGC), for example,…
Read More
Cannabis stocks have had a tough year. Since the summer, most marijuana ETFs have been cut in half. Yet the long-term promise remains clear. Many analysts expect global sales to hit $100 billion by 2030, representing 1,000% growth. If you want to invest in cannabis stocks, it pays to have a multi-year vision. Still, short-term market gyrations can make some…
Read More
E-cigarettes are currently roiled in controversy, albeit sales growth remains positive. Looking back, it’s amazing how quickly this industry emerged. In 2013, the global vaping market was worth just $4 billion. This year, it’s expected to approach $20 billion, which represents 500% growth in just six years. By 2023, Euromonitor International expects the market size to surpass $45 billion. Given…
Read More
Shares of Canada’s leading cannabis company Canopy Growth (TSX:WEED)(NYSE:CGC) fell 14.5% yesterday after it announced fiscal second quarter of 2020 (year ending in March) results. In the September quarter, Canopy Growth reported sales of $76.6 million, a year-over-year growth of 228% compared to sales of $23.33 million in the prior-year period. The company’s earnings per share improved from -$1.52 to…
Read More